Soleno Therapeutics Achieves Historic Q3 Milestone: VYKAT XR Drives Company to First Profitable Quarter

Soleno Therapeutics marked a significant turning point in its corporate history by reporting its first profitable quarter, driven by robust sales of VYKAT XR, its groundbreaking therapy for Prader-Willi Syndrome…

Continue Reading Soleno Therapeutics Achieves Historic Q3 Milestone: VYKAT XR Drives Company to First Profitable Quarter